A preliminary in vitro evaluation of the bioactive potential of cryogel scaffolds incorporated with Manuka honey for the treatment of chronic bone infections. Issue 5 (27th September 2017)

• Record Type: Journal Article
• Authors: Hixon, Katherine R.; Lu, Tracy; Carletta, Marissa N.; McBride‐Gagyi, Sarah H.; Janowiak, Blythe E.; Sell, Scott A.
• Is Part Of: Journal of biomedical materials research. Volume 106:Issue 5(2018)
• Page Start: 1918
• Page End: 1933
• Publication Date: 2017-09-27
• Subjects: bactericidal -- cryogels -- Manuka honey -- scaffolds -- tissue engineering; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/jbm.b.34002
• Languages: English
• ISSNs: 1552-4973

Abstract

Abstract: Previous studies have identified honey as an agent in bacterial inhibition and a mediator in lowering the pH at the wound site. Manuka honey (MH), indigenous to New Zealand, contains a Unique Manuka Factor that provides an additional antibacterial agent. While there are many potential benefits to incorporating MH into wounds, there is currently no ideal way to deliver the material to the site of injury. Cryogels are a type of scaffold that possess high porosity, mechanical stability, and a sponge‐like consistency. This study uniquely incorporates varying amounts of MH into cryogel scaffolds, utilizing its properties in a sustained release fashion to assist in the overall healing process, while using the cryogel structure as a tissue template. All cryogels were evaluated to determine the effects of MH on porosity, swelling potential, mechanical durability, and cell compatibility. The release of MH was also quantified to evaluate bacterial clearance potential, and the scaffolds were mineralized to replicate native bone. It was determined that a 5% MH silk fibroin cryogel has the potential to inhibit bacterial growth while still maintaining adequate porosity, mechanical properties, and cell infiltration. Such a scaffold would have use in a number of applications, including bone regeneration. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1918–1933, 2018.